STK11 and central nervous system cancer: Mutations in the tumor suppressor LKB1 limit AMPK activity and the production of NADPH through catabolic processes; unrestrained ROS can promote tumor growth by boosting oncogenic signal transduction, genetic instability and glioma growth in vivo (Jeon et al., 2012).